As of 2024-12-14, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 14.20 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is 952.2%.
The range of the Relative Valuation is 9.31 - 20.25 CAD.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 10.0x | 8.5x |
| Forward P/E multiples | 10.5x - 15.2x | 12.8x |
| Fair Price | 9.31 - 20.25 | 14.20 |
| Upside | 589.9% - 1400.1% | 952.2% |
| Date | P/E |